Search by Drug Name or NDC
NDC 00573-0145-72 ADVIL DUAL ACTION WITH ACETAMINOPHEN 250; 125 mg/1; mg/1 Details
ADVIL DUAL ACTION WITH ACETAMINOPHEN 250; 125 mg/1; mg/1
ADVIL DUAL ACTION WITH ACETAMINOPHEN is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; IBUPROFEN.
Product Information
| NDC | 00573-0145 |
|---|---|
| Product ID | 0573-0145_acaa9806-e552-44f2-a680-b8bb64c49e1f |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | ADVIL DUAL ACTION WITH ACETAMINOPHEN |
| Proprietary Name Suffix | Back Pain |
| Non-Proprietary Name | Ibuprofen, Acetaminophen |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 125 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; IBUPROFEN |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA211733 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00573-0145-72 (00573014572)
| NDC Package Code | 0573-0145-72 |
|---|---|
| Billing NDC | 00573014572 |
| Package | 1 BOTTLE in 1 CARTON (0573-0145-72) / 72 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2023-01-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |